Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02729480 · ClinicalTrials.gov registry record · NA
Clinical Trial of Wireless CranioFacial Nerve Stimulation (CFNS) for the Treatment of CranioFacial Neuropathic Pain
A NA study, sponsored by Curonix.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02729480 is a NA study that has completed, run by Curonix. The registered enrollment target is 60 participants.
The verdict
NCT02729480, a NA study, has completed, sponsored by Curonix.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effectiveness of craniofacial nerve stimulation for the treatment of neuropathic pain.
Interventions
- DEVICE Halo Craniofacial Nerve Stimulator System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2022-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02729480
The ClinicalTrials.gov registry entry for NCT02729480 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Curonix, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Halo Craniofacial Nerve Stimulator System is the first listed.
NCT02729480 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02729480 about?
NCT02729480 is a clinical study titled "Clinical Trial of Wireless CranioFacial Nerve Stimulation (CFNS) for the Treatment of CranioFacial Neuropathic Pain". The purpose of this study is to assess the effectiveness of craniofacial nerve stimulation for the treatment of neuropathic pain.
What is the current status of trial NCT02729480?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2017-02-01. Estimated completion is 2022-10-01.
What interventions are being tested in trial NCT02729480?
The interventions under investigation include: Halo Craniofacial Nerve Stimulator System (DEVICE).
Who is sponsoring clinical trial NCT02729480?
This trial is sponsored by Curonix, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.